Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia - Concepedia

Concepedia

Publication | Closed Access

Double-Blind, Placebo-Controlled, Multicenter Trial of Selegiline Augmentation of Antipsychotic Medication to Treat Negative Symptoms in Outpatients With Schizophrenia

56

Citations

7

References

2005

Year

J. Alexander Bodkin, Samuel G. Siris, Paul C. Bermanzohn, John Hennen, Jonathan Cole

American Journal of Psychiatry

Abstract

These findings support further investigation of low-dose selegiline augmentation of antipsychotic medication in outpatients with schizophrenia who have at least a moderate burden of negative symptoms.

References

	Year	Citations

Page 1